mediaire

Quantitative neuroimaging is particularly meaningful for the early detection and differentiation of Dementia, as well as for the assessment of lesion dynamics in Multiple Sclerosis.
mediaire offers (neuro)radiologists a detailed brain volumetry and lesion report for each patient by an automated, AI-based MRI analysis within just 5 minutes locally in their centre.
The radiologist can therefore talk through the MR report within the same patient appointment.
Our first product family with mdbrain & mdspine is already certified as a medical device in Europe according to DIN EN ISO 13485:2016.
mediaire’s software mdbrain is platform-independent, completely integrated into the radiologists’ local IT system and connected to the PACS to ensure highest possible safety of patient data.

Company’s Keywords:

radiology, imaging biomarker, brain volumetry, artificial intelligence, quantitative imaging, multiple scleroris, alzheimers disease, image postprocessing, mrimaging, dementia, lesion quantification, lesion characterisation, image analysis, image quality, neuroimaging